Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Burhan Turgut, Ozden Vural, Funda S. Pala, Gülsüm E. Pamuk, Kiymet TabakcioĞlu, Muzaffer Demir, Şeniz Öngören, Teoman Soysal & Çetin Algüneş. (2007) 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis. Leukemia & Lymphoma 48:2, pages 311-320.
Read now
Read now
Suneel Mundle & Yelina Noskina. (2005) Cytogenetic testing for therapeutic indication in cancer. Expert Review of Molecular Diagnostics 5:1, pages 23-29.
Read now
Read now
Articles from other publishers (19)
María Velasco-de Andrés, Sergi Casadó-Llombart, Cristina Català, Alejandra Leyton-Pereira, Francisco Lozano & Fernando Aranda. (2020) Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents. Cells 9:12, pages 2589.
Crossref
Crossref
Li Wan, Lin Zhang, Kai Fan, Zai-Xing Cheng, Quan-Chao Sun & Jian-Jun Wang. (2016) Knockdown of Long Noncoding RNA PCAT6 Inhibits Proliferation and Invasion in Lung Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 24:3, pages 161-170.
Crossref
Crossref
XI CHEN, XIU-SHUAI DONG, HAI-YAN GAO, YONG-FANG JIANG, YING-LAN JIN, YU-YING CHANG, LI-YAN CHEN & JING-HUA WANG. (2016) Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells. Molecular Medicine Reports 13:1, pages 689-696.
Crossref
Crossref
Yuanzhou He, Xiaopei Cao, Xiansheng Liu, Xiaochen Li, Yongjian Xu, Jin Liu & Jing Shi. (2015) Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway. Experimental Cell Research 339:1, pages 122-134.
Crossref
Crossref
Anurag Saxena, Oksana V. Moshynska, Igor D. Moshynskyy, Evan D. Neuls, Tania Qureshi, Mark Bosch, Michael Voralia & Keith Bonham. (2007) Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression. Cancer Letters 251:1, pages 114-131.
Crossref
Crossref
Sukru Palanduz, Nedime Serakinci, Kivanc Cefle, Melih Aktan, Gulcin Tutkan, Sukru Ozturk, Gokay Bozkurt, Guncag Dincol, Yuksel Pekcelen & Jørn Koch. (2006) A different approach to telomere analysis with ddPRINS in chronic lymphocytic leukemia. European Journal of Medical Genetics 49:1, pages 63-69.
Crossref
Crossref
O. Moshynska, K. Sankaran, P. Pahwa & A. Saxena. (2004) Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia. JNCI Journal of the National Cancer Institute 96:9, pages 673-682.
Crossref
Crossref
Anurag Saxena, Sathiyanarayanan Viswanathan, Oksana Moshynska, Puneeta Tandon, Koravangattu Sankaran & David P. Sheridan. (2003) Mcl‐1 and Bcl‐2/Bax ratio are associated with treatment response but not with Rai stage in B‐cell chronic lymphocytic leukemia. American Journal of Hematology 75:1, pages 22-33.
Crossref
Crossref
George B Segel, Timothy J Woodlock, Jia Xu, Liqiong Li, Raymond E Felgar, Daniel H Ryan, Marshall A Lichtman & Nancy Wang. (2003) Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype. Blood Cells, Molecules, and Diseases 30:3, pages 277-287.
Crossref
Crossref
Anna Zaninoni, Francesca Guia Imperiali, Cristina Pasquini, Alberto Zanella & Wilma Barcellini. (2003) Cytokine modulation of nuclear factor-κB activity in B-chronic lymphocytic leukemia. Experimental Hematology 31:3, pages 185-190.
Crossref
Crossref
Anurag Saxena, Oksana Moshynska, Koravangattu Sankaran, Sathiyanarayanan Viswanathan & David P Sheridan. (2002) Association of a novel single nucleotide polymorphism, G(−248)A, in the 5′-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance. Cancer Letters 187:1-2, pages 199-205.
Crossref
Crossref
Nora G. Singer, David A. Fox, Tariq M. Haqqi, Laura Beretta, Judith S. Endres, Susan Prohaska, Jane R. Parnes, Jonathan Bromberg & R. Michael Sramkoski. (2002) CD6: expression during development, apoptosis and selection of human and mouse thymocytes. International Immunology 14:6, pages 585-597.
Crossref
Crossref
Neil E. Kay, Lei Han, Nancy Bone & Gary Williams. (2001)
Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8
+
T cells from B‐CLL patients: impact on clonal B‐cell apoptosis
. British Journal of Haematology 112:3, pages 760-767.
Crossref
Crossref
Brigitte Bauvois, Mojgan Djavaheri-Mergny, Dany Rouillard, Janine Dumont & Juana Wietzerbin. (2000) Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene 19:2, pages 265-272.
Crossref
Crossref
R. N. Damle, F. Fais, F. Ghiotto, A. Valetto, E. Albesiano, T. Wasil, F. M Batliwalla, S. L Allen, P. Schulman, V. P. Vinciguerra, K. R. Rai, P. K. Gregersen, M. Ferrarini & N. Chiorazzi. 2000. B1 Lymphocytes in B Cell Neoplasia. B1 Lymphocytes in B Cell Neoplasia
285
292
.
M Aguilar-Santelises, D Gigliotti, LM Osorio, A Santiago, H Mellstedt & M Jondal. (1999) Cytokine expression in B-CLL in relation to disease progression andin vitro activation. Medical Oncology 16:4, pages 289-295.
Crossref
Crossref
Jonathan F. Williams, Matthew J. Petrus, Jacob A. Wright, Anne Husebekk, Vicki Fellowes, Elizabeth J. Read, Ronald E. Gress & Daniel H. Fowler. (2002) Fas‐mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous FasL‐expressing T cells. British Journal of Haematology 107:1, pages 99-105.
Crossref
Crossref
B. Bauvois, L. Durant, J. Laboureau, E. Barthelemy, D. Rouillard, G. Boulla & P. Deterre. (1999) Upregulation of CD38 Gene Expression in Leukemic B Cells by Interferon Types I and II. Journal of Interferon & Cytokine Research 19:9, pages 1059-1066.
Crossref
Crossref
Lyda M Osorio & Miguel Aguilar-Santelises. (1998) Apoptosis in B-chronic lymphocytic leukaemia. Medical Oncology 15:4, pages 234-240.
Crossref
Crossref